 |
|
Bone Remodeling and Modeling: Cellular Targets for Antiresorptive and Anabolic Treatments, Including Approaches Through the Parathyroid Hormone (PTH)/PTH-Related Protein Pathway
Thomas John Martin, Ego Seeman
Neurospine. 2023;20(4):1097-1109. Published online 2023 Dec 31 DOI: https://doi.org/10.14245/ns.2346966.483
|
|
Citations to this article as recorded by
 Advances in assessment and treatment of bone, mineral and parathyroid disorders
Samuel D. Vasikaran
Current Opinion in Endocrinology, Diabetes & Obesity.2024; 31(4): 139. CrossRef Promotion of Bone Formation in a Rat Osteoporotic Vertebral Body Defect Model via Suppression of Osteoclastogenesis by Ectopic Embryonic Calvaria Derived Mesenchymal Stem Cells
Yerin Yu, Somin Lee, Minsung Bock, Seong Bae An, Hae Eun Shin, Jong Seop Rim, Jun-oh Kwon, Kwang-Sook Park, Inbo Han
International Journal of Molecular Sciences.2024; 25(15): 8174. CrossRef Bone Mineral Density, C-Terminal Telopeptide of Type I Collagen, and Osteocalcin as Monitoring Parameters of Bone Remodeling in CML Patients Undergoing Imatinib Therapy: A Basic Science and Clinical Review
Nurita Indarwulan, Merlyna Savitri, Ami Ashariati, Siprianus Ugroseno Yudho Bintoro, Muhammad Noor Diansyah, Putu Niken Ayu Amrita, Pradana Zaky Romadhon
Diseases.2024; 12(11): 275. CrossRef From the Editor-in-Chief: Featured Articles in the December 2023 Issue
Inbo Han
Neurospine.2023; 20(4): 1093. CrossRef Cellular Basis for Sequencing of Antiresorptive and Anabolic Therapies for Bone: Commentary on “Bone Remodeling and Modeling: Cellular Targets for Antiresorptive and Anabolic Treatments, Including Approaches Through the Parathyroid Hormone (PTH)/PTH-Relat
Natalie A. Sims
Neurospine.2023; 20(4): 1110. CrossRef
|